Almost one in three deaths (32 %) in men were caused
by cancer compared with 29 % for cardiovascular disease.
Not exact matches
Comparing the teaching of one of the best scrutinized and accepted (and best supported
by evidence) scientific theories to selling a product known to cause
cancer is actually quite funny.
In addition, an analysis of the corrected rates over the decade revealed that white women's rates of death from cervical
cancer decreased
by 0.8 percent per year,
compared with an annual decrease of 3.6 percent in black women.
In women, death rates from breast and colorectal
cancer will fall
by 8 % and 7 % respectively, but lung and pancreatic
cancer rates will rise
by 5 % and 4 %; in 2016 the death rates from lung
cancer in Europe will be 14.4 per 100,000 women (
compared to 13.51 in 2011) and 5.6 per 100,000 for pancreatic
cancer (
compared to 5.39 in 2011).
By comparing with other already known factors, HAND2 methylation is by far the most common molecular alteration in endometrial cance
By comparing with other already known factors, HAND2 methylation is
by far the most common molecular alteration in endometrial cance
by far the most common molecular alteration in endometrial
cancer.
So says a five - year retrospective study led
by Malcolm Dunlop of the University of Edinburgh, UK, that
compared the aspirin habits of 2800 people with
cancer and 3000 without.
Two studies published
by JAMA
compare certain outcomes of robotic - assisted vs laparoscopic surgery for kidney removal or rectal
cancer.
A fundamental error, according to several epidemiologists, is that Tsuda
compared the results of the Fukushima survey, which used advanced ultrasound devices that detect otherwise unnoticeable growths, with the roughly three cases of thyroid
cancer per million found
by traditional clinical examinations of patients who have lumps or symptoms.
In testing on two mouse cell lines, the drug combination reduced the viability of
cancer cells
by about 50 percent when
compared with everolimus alone, according to the findings.
These carriers were found to have only a 56 % chance of developing breast
cancer by age 70,
compared with a figure of 87 % in previous studies.
Analysis of the data indicated that
compared to no screening, flexible sigmoidoscopy screening reduced colorectal
cancer incidence
by 20 percent (absolute difference, 28.4 cases / 100, 000 person years) and colorectal
cancer mortality
by 27 percent (absolute difference, 11.7 deaths / 100, 000 person years).
Albiges's team followed up on Furberg and Hakimi's work
by comparing survival rates of normal weight and obese individuals with kidney
cancer that had metastasized.
By comparing women in the lowest - BMI category with those in successively higher ones, they found a steadily decreasing risk of the
cancer.
Researchers from BUSM and the University of Cyprus
compared the markers on the surface of the
cancer cells to gene expression profile of breast tumors deposited
by researchers in international public databases and found that a molecule named IL13RA2 (IL13R alpha2) was abundant in metastatic or late - stage BLBC.
In tumors formed
by human breast
cancer cells, DNA damage (brown staining) is increased
by simultaneous Olaparib treatment and PGAM1 suppression (right) when
compared to either Olaparib treatment (left) or PGAM1 suppression (center) alone.
In a randomized, phase 2 multi-center clinical study, led
by Manisha Shah, MD of The Ohio State University Comprehensive
Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf muta
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf muta
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone
compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid
cancer patients with B - raf muta
cancer patients with B - raf mutations.
Among healthy postmenopausal women, supplementation with vitamin D3 and calcium
compared with placebo did not result in a significantly lower risk of
cancer after four years, according to a study published
by JAMA.
By comparing normal cells to
cancer cells, scientists can then identify the changes that lead to disease.
The enrichment factor described how frequently
cancer associated genes were identified
compared to the frequency of identification that one could expect
by pure chance.
The period of time before ovarian
cancer recurred (called progression - free survival) improved
by nearly 3.5 months with the additional drug (13.8 months
compared with 10.4 months for the woman on chemotherapy alone).
The team was led
by Dr Stephen Royle reader and senior
Cancer Research UK fellow at Warwick Medical School said: «We've
compared our method to «hot - wiring» a car.
They estimate that this screening strategy would reduce lung
cancer mortality
by 9.05 %
compared to no screening, with an incremental cost - effectiveness ratio of $ 41,136 Canadian dollars per life - year gained.
They tested DBT and DM according to four outcomes — true positive (TP), true negative (TN), false positive (FP), and false negative (FN) rates —
by comparing the Breast Imaging Reporting and Data System (BI-RADS) score (assigned at screening with data about subsequent
cancer diagnosis).
«The genome of these
cancer cells is less abnormal as
compared to
cancers caused
by tobacco and alcohol, where there are even more mutations present,» he says.
The researchers were able to replicate this finding
by comparing the healthy thyroid tissues in GTEx to 500 samples taken from thyroid tumors, compiled
by The
Cancer Genome Atlas, and giving support to the extensive impact of FOXE1 on cellular state.
A new study
by UCLA scientists has found that women diagnosed with breast
cancer and treated with a one - week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in
cancer recurrence or difference in cosmetic outcomes
compared to women who received radiation of the entire breast for a period of up to six weeks after surgery.
Most excitingly,
by comparing between individual cells, the team expect to reveal differences which could play key roles in both the early stages of life and the first stages of diseases such as
cancer.
However, CVD is the top killer of women in Europe, resulting in 51 % of deaths
compared to 3 % caused
by breast
cancer.»
When
comparing the
cancer risk of EPIC participants with extremely high or extremely low immunoCRIT, the researchers found that if the value is strongly increased, the lung
cancer risk rises
by 100 percent, and the risk of colon
cancer by approximately 60 percent.
The researchers, funded
by the Medical Research Council (MRC), the Wellcome Trust and
Cancer Research UK, compared the effects of two cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out
Cancer Research UK,
compared the effects of two
cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out
cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out mice).
An additional set of 18 prostate
cancer tissue samples was analyzed
by qPCR and five lncRNAs were found to be significantly higher in prostate tumor tissues
compared with matched normal tissues.
Women whose mothers had elevated levels of DDT in their blood had a nearly fourfold increase in risk of developing breast
cancer by age 52,
compared with controls who were matched for a variety of factors, including maternal history of breast
cancer.
Women with heart failure after
cancer treatment were more likely to be treated with standard medications if seen
by a cardiologist
compared with those who did not see a cardiologist.
«Once identified, we further tested their role as
cancer drivers, for example
by looking at molecules with and without mutations and
comparing their structure and function,» he adds.
The data for the current analysis
compared the effect of selenium and vitamin E, taken either alone or combined, on prostate
cancer risk among 1,739 men who were diagnosed with prostate
cancer and, for comparison purposes, a random sample of 3,117 men without prostate
cancer who were matched to the cases
by race and age.
Mortality in prostate
cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY
cancer is lower in areas with frequent use of PSA testing
compared with areas with little testing shows a study published online today in Journal of the National
Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY
Cancer Institute
by researchers from Umeå University, Sweden and Memorial Sloan Kettering
Cancer Center, New York, NY
Cancer Center, New York, NY, USA.
Given the widespread use of the HeLa cell line, Lars Steinmetz and his colleagues at EMBL decided that conducting an extensive analysis of its genome could illustrate the changes caused
by cancer — and also help researchers
compare versions of the cell line that have evolved over decades of growth in labs around the world.
A team led
by James Farrell of the University of California, Los Angeles,
compared the bacteria in the mouths of 10 healthy people with those in 10 people with pancreatic
cancer.
They started
by comparing cancer stem cells to noncancerous neural stem cells.
When they
compared the timing and provision of hospice care between patients treated
by the VA and those who received care paid for
by Medicare, they discovered differences that could not be explained
by cancer types.
The men receiving docetaxel had an average of 32.7 months before the
cancer progressed
by worsening scan results or symptoms,
compared to 19.8 months for hormone therapy alone.
The international team of researchers modeled the lifetime risk of women developing radiation - induced breast
cancer from digital screening mammography and dying from the disease
compared to the number of breast
cancer deaths prevented
by early detection.
Head and neck
cancers survival in England is generally higher for people diagnosed aged 15 - 49
compared with other age groups, though the association with age varies
by subtype.
The team
compared «age and gender - specific incidence rates of 19,858 male and 14,222 females diagnosed with brain
cancer between 1982 and 2012, and mobile phone usage data from 1987 to 2012,» writes lead researcher Simon Chapman in the study, published
by
By comparing different generations at similar ages, it found that people born around 1990 have double the risk of colon
cancer and quadruple the risk of rectal
cancer of people born around 1950.
Patients with metastatic castration - resistant prostate
cancer (CRPC) had higher prostate - specific antigen (PSA) response when treated with enzalutamide compared with abiraterone / prednisone, but had no difference in time to progression or time to PSA progression, according to the results of a study (abstract 5002) presented by Kim N. Chi, MD, of the British Columbia Cancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 &mda
cancer (CRPC) had higher prostate - specific antigen (PSA) response when treated with enzalutamide
compared with abiraterone / prednisone, but had no difference in time to progression or time to PSA progression, according to the results of a study (abstract 5002) presented
by Kim N. Chi, MD, of the British Columbia
Cancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 &mda
Cancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6.
The addition of metronomic chemotherapy to dual HER2 blockade increased progression - free survival (PFS)
by 7 months
compared with HER2 blockade alone in older and frail patients with HER2 - positive metastatic breast
cancer, according to a new study.
Led
by St. Jude and the German
Cancer Research Center, an international research team used molecular techniques to
compare hundreds of tumors classified as CNS - PNET to other known brain tumors.
A new technique of robotic partial nephrectomy has the potential for better preservation of kidney function and better
cancer control during partial nephrectomy
by allowing surgeons more time to perform the procedure
compared with traditional open surgery, according to the results of a recently published case series.
When tested on 335 high - risk lesions, the model correctly diagnosed 97 percent of the breast
cancers as malignant and reduced the number of benign surgeries
by more than 30 percent
compared to existing approaches.